Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions.
Clin Ophthalmol. 2022 Nov 17;16:3803-3809. doi: 10.2147/OPTH.S389688. eCollection 2022.
Clin Ophthalmol. 2022.
PMID: 36419563
Free PMC article.
Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma.
Okeke CO, Burstein ES, Trubnik V, Deom JE, Cooper MS, Brinkley DA, Thimons JJ, Kabiri AJ, Gelb KM.
Okeke CO, et al. Among authors: deom je.
Ophthalmol Ther. 2020 Dec;9(4):1041-1053. doi: 10.1007/s40123-020-00307-0. Epub 2020 Oct 7.
Ophthalmol Ther. 2020.
PMID: 33034885
Free PMC article.
Item in Clipboard
Latanoprostene Bunod 0.024% in Patients with Open-Angle Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Chart Review.
Okeke CO, Cothran NL, Brinkley DA, Rahmatnejad K, Rodiño FJ, Deom JE.
Okeke CO, et al. Among authors: deom je.
Clin Ophthalmol. 2024 Feb 7;18:409-422. doi: 10.2147/OPTH.S442940. eCollection 2024.
Clin Ophthalmol. 2024.
PMID: 38348139
Free PMC article.
Item in Clipboard
Cite
Cite